Showing 1 posts of 1 posts found.
Conatus Pharmaceuticals has announced the appointment of Daniel Ripley as head of Corporate Development. Ripley will lead the commercialisation strategy …
NEC joins €6.5m European project using AI for pandemic vaccine design
The evidence bar impacting UK medical cannabis access
Survey highlights mental health burden among rare disease patients and families
Addressing the rheumatic disease diagnostic gap in primary care
How chronic disease creates opportunity on diagnostic and therapeutic pipelines